期刊文献+

ER、PR及PS_2基因在乳腺癌中的表达及其临床意义 被引量:4

The expression of ER,PR and PS_2 in breast cancer and its chinical significance
下载PDF
导出
摘要 目的探讨雌激素调节蛋白PS2在乳腺癌中的表达及其临床病理间的关系。方法采用免疫组织化学SABC法对68例乳腺癌中ER、PR及PS2进行检测,分析其与ER、PR及预后的关系。结果PS2与ER显著正相关。在ER(+)PR(+)的病例中,PS2阳性表达率为52.0%,而在ER(-)PR(-)的病例中,PS2阳性率仅为14.3%,二者相比差异有统计学意义(P<0.01)。PS2的表达与患者年龄、肿瘤大小无关(P>0.05),而与腋下淋巴结状况有关(P<0.01)。结论在乳腺癌中PS2的表达与ER、PR呈正相关关系,并与腋下淋巴结状况有关。PS2可以作为预测乳腺癌预后的一项重要指标。 Objective Discussing the relationship between the PS2 estrogen-regulated protein expression in breast cancer and clinical pathology. Methods Testing 68 eases of breast cancer in the ER,PR and PS2 with immunohistochemistry SABC law. Results PS2 and ER were related Obviously. In the cases of the ER ( + ) and PR( + ) ,PS2 positive rate was 52. 0% ,and in the the cases OfER (-) PR (-) ,PS2 positive rate was only 14. 3% , the difference was obvious (P 〈 0.01 ). PS2 bad not relation with the age of the patients and the size of the tumor(P 〉0.05) ,but had trelation with the axiUary lymph nodes(P 〈0. 01 ). Conclusion The PS2 in breast cancer and the ER, PR are related, which have relation with Axillary lymph nodes. PS2 can predict breast cancer as an important indicator of prognosis.
出处 《中国实用医药》 2008年第35期19-20,共2页 China Practical Medicine
关键词 雌激素受体ER 孕激素受体PR 雌激素调节蛋白PS2 乳腺癌 表达 ER PR PS2 Breast cancer Expression
  • 相关文献

参考文献5

  • 1[1]Kelleher M,Miles D.The adjuvangt treatment of breast cancer,Int J Clin Pract,2003,57(3):195-199.
  • 2[2]Thompson AM,Hawkins RS,Elton RA,et al.PS2 is an independent factor of good prognosis in primary breast cancer.Br J Cancer,1993,68(1):93-96.
  • 3[3]Gion M,Mione R,Pappagallo GL,et al.PS2 in breast cancer;alternative or comptementary tool to stersid recept or status evaluation of 446 cases.Br J Cancer,1993,68(2):374-379.
  • 4[4]Detre S,King N,Saleter J,et al.Immunohistochemical and biochemical analysis of the oestrogen receptor and progesterone receptor in breast cancer.J Clin Pathol,1994,47(3):240-244.
  • 5丁秀敏,何振祥,张文萍,方志沂,赵颖.雌激素调节蛋白PS2在乳腺癌组织中的表达及其应用[J].实用肿瘤杂志,2001,16(4):235-237. 被引量:8

二级参考文献3

  • 1张克勤 丁秀敏 等.139例原发乳腺癌雌激素受体的分析[J].肿瘤防治研究,1987,14(2):67-70.
  • 2Detre S,J Clin Pathol,1994年,47卷,3期,240页
  • 3张克勤,肿瘤防治研究,1987年,14卷,2期,67页

共引文献7

同被引文献25

  • 1汪波,管忠震,刘冬耕,林桐榆,张力,夏忠军,滕小玉.雌、孕激素受体及HER-2受体在乳腺癌原发灶及复发转移灶之间的表达差异[J].癌症,2004,23(12):1710-1713. 被引量:13
  • 2薄爱华,程琳,李海峰,赵荧,张晓丽,邢立强.表皮生长因子受体与肿瘤发生及治疗的相关性[J].医学综述,2006,12(20):1238-1240. 被引量:15
  • 3Browne BC,O'Brien N,Duffy MJ,et al.HER-2 signaling and inhibition in breast cancer[J].Curr Cancer Drug Targets,2009,9(3):419-438.
  • 4Park JW, Neve RM,Szollosi J,et al.Unraveling the biologic and clinical complexities of HER2[J].Clin Breast Cancer,2008,8(5):392-401.
  • 5Mc Cormack O,Harrison M,Kerin MJ,et al.Role of the progesterone receptor (PR) and the PR isoforms in breast cancer[J].Crit Rev Oncog, 2007,13(4):283-301.
  • 6Ishikawa M,Kitayama J,Kazama S,et al.Expression of vascular endothelial growth factor C and D(VEGF-C and-D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma[J].Jpn J Clin Oncol,2003;33(1):21-7.
  • 7Matk B,Jure A,Sepa V,et al.Immunhistochemical analysis of ER,PR,HER-2,CK5/6,P63 and EGFR antigen expression in medullary breast cancer[J].Tumori,2008;94(6):838-44.
  • 8J.Daniel Bergstr?m,Bengt Westermark,Nils-Erik Heldin.Epidermal Growth Factor Receptor Signaling Activates Met in Human Anaplastic Thyroid Carcinoma Cells[J].Experimental Cell Research.2000(1)
  • 9Takeshi Yasunami,Yan-hua Wang,Kazue Tsuji,Minoko Takanashi,Yasuaki Yamada,Toshiko Motoji.Multidrug resistance protein expression of adult T-cell leukemia/lymphoma[J]. Leukemia Research . 2006 (4)
  • 10Zhang Kai Guang,Qin Cheng Yong,Wang Hui Qun,Wang Jun Xian.The Effect of TRAIL on the Expression of Multidrug Resistant Genes MDR1, LRP and GST-π in Drug-Resistant Gastric Cancer Cell SGC7901/VCR. Hepato Gastroenterology . 2012

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部